Influenza drug "Zofluza" is carefully administered to children under 12 years old on October 17 at 5:03
In response to the emergence of a resistant virus that is difficult to use this drug from patients who took Zofluza, the most commonly used new treatment for influenza last season, the Japanese Society for Infectious Diseases was given to children under 12 years of age. New proposals to make the process more cautious.
A new treatment for influenza, Zofluza, has become a challenge because resistant viruses are likely to occur, and the Japanese Society for Infectious Diseases has discussed how to use it.
According to a new recommendation made by the academic society, children under 12 years of age tend to detect more resistant viruses than adults. The data is scarce and we ca n’t decide whether to recommend it at the moment. ”
Zofluza developed by Shionogi & Co., Ltd. has been used most often when it was launched last year, as it would be effective with a single dose. Approximately 6 million people were shipped in half a year alone.
As for Zofluza, the academic society has an effect different from the widely used “Tamiflu”, and it can be used for patients who do not work with Tamiflu or who are concerned about the severity, so do not spread the resistant virus with careful use It is important.
A new recommendation is that it will be posted on the academic society's website soon. The officials of the academic society said, “I want you to think about how to use Zofluza in an emergency.”